TherapeuticsMD (TXMD)
Q4 2018 Earnings Conference Call
February 21, 2019 4:30 PM ET
Company Participants
Nichol Ochsner - Vice President of Investor Relations
Robert Finizio - Chief Executive Officer
Daniel Cartwright - Chief Financial Officer
Brian Bernick - Co-Founder & Director
Dawn Halkuff - Chief Commercial Officer
Conference Call Participants
Ken Cacciatore - Cowan & Co.
Louise Chen - Cantor Fitzgerald
Annabel Samimy - Stifel
Jay Olson - Oppenheimer
Chris Schott - JPMorgan
Michael Scott - Goldman Sachs
Presentation
Operator
Good afternoon, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD's Fourth Quarter